“…Over the past three decades, research on eating disorders (EDs) including anorexia nervosa (AN) has explored a variety of psychological as well as pharmacological strategies to enhance outcomes in the hopes of improving well‐recognized challenges with modest response rates for evidence‐based treatments (de Rijk et al, 2023; Fornaro et al, 2023; Zhu et al, 2023; Monteleone et al, 2022; Steinhausen, 2009). Despite best efforts to optimize treatment success, AN has the continued undesirable distinction of having the highest mortality rate of all psychiatric disorders (Arcelus et al, 2011), while reviews suggests that only half of youth remit after gold‐standard treatments such as manualized family based therapy are received (Schlegl et al, 2020; Touyz et al, 2023). While benefits of manualized treatments are numerous, and include the use of evidence‐based treatments, facilitation of research, training, treatment dissemination, and treatment fidelity using structured and standardized protocols that can be tested and evaluated, limitations are also abundant.…”